Rhenman & Partners Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.35M Sell
15,200
-20,800
-58% -$7.42M 0.66% 55
2025
Q4
$11.8M Buy
+36,000
New +$11.4M 1.1% 35
2025
Q2
Sell
-4,000
Closed -$1.25M 91
2025
Q1
$1.25M Buy
4,000
+1,000
+33% +$295K 0.14% 80
2024
Q4
$782K Hold
3,000
0.08% 89
2024
Q3
$967K Sell
3,000
-1,250
-29% -$409K 0.08% 94
2024
Q2
$1.33M Hold
4,250
0.13% 85
2024
Q1
$1.21M Sell
4,250
-250
-6% -$73.2K 0.11% 81
2023
Q4
$1.3M Buy
+4,500
New +$1.23M 0.13% 80
2017
Q3
Sell
-35,000
Closed -$6.03M 96
2017
Q2
$6.03M Sell
35,000
-65,000
-65% -$10.6M 0.87% 46
2017
Q1
$16.4M Buy
100,000
+35,000
+54% +$5.82M 2.6% 5
2016
Q4
$9.5M Buy
65,000
+10,000
+18% +$1.51M 1.82% 19
2016
Q3
$9.17M Sell
55,000
-6,500
-11% -$1.1M 1.46% 22
2016
Q2
$9.36M Buy
61,500
+16,500
+37% +$2.57M 1.66% 20
2016
Q1
$6.75M Sell
45,000
-37,000
-45% -$5.5M 1.34% 32
2015
Q4
$13.3M Sell
82,000
-53,000
-39% -$8.33M 2.01% 10
2015
Q3
$18.7M Buy
135,000
+66,000
+96% +$10.4M 2.98% 1
2015
Q2
$10.6M Sell
69,000
-30,000
-30% -$4.81M 1.27% 23
2015
Q1
$15.8M Buy
99,000
+59,832
+153% +$9.42M 2.67% 6
2014
Q4
$6.24M Buy
39,168
+16,168
+70% +$2.52M 1.81% 15
2014
Q3
$3.23M Buy
23,000
+8,000
+53% +$1.04M 0.95% 38
2014
Q2
$1.78M Sell
15,000
-31,135
-67% -$3.6M 0.53% 69
2014
Q1
$3.95M Buy
+46,135
New +$5.6M 1.19% 28

Other funds holding AMGN

Rhenman & Partners Asset Management's AMGN Position: Q1 2026 in Review

Rhenman & Partners Asset Management reduced its Amgen (AMGN) stake by 58% in Q1 2026, selling an estimated $7.42M and leaving 15,200 shares worth $5.35M. The position accounts for 0.66% of the portfolio, ranked #55.

Rhenman & Partners Asset Management first reported a position in AMGN in Q1 2014 and has held it in 22 quarters since. The position peaked at $18.7M in Q3 2015. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Rhenman & Partners Asset Management held 15,200 shares of Amgen worth $5.35M as of Q1 2026.
  • Rhenman & Partners Asset Management sold 20,800 Amgen shares in Q1 2026, an estimated $7.42M.
  • Amgen made up 0.66% of Rhenman & Partners Asset Management's portfolio in Q1 2026, its #55 holding.
  • Rhenman & Partners Asset Management first reported a position in Amgen in Q1 2014 and has held it in 22 quarters since.
  • Rhenman & Partners Asset Management's Amgen position peaked at $18.7M in Q3 2015.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Rhenman & Partners Asset Management's 13F filing for Q1 2026, filed 14 May 2026.